Tuberculin, Purified Protein Derivative (Tubersol) Report issue

Vaccine Approved FDA
AACT ChEMBL DrugBank

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

United States

$2.1106 - $48.0100
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

aplisol | aplitest | mycobacterium tuberculosis purified protein derivative | purified protein derivative of tuberculin | tine test | tine test ppd | tuberculin | tuberculin, old | tuberculin ppd | tuberculin purified protein derivative | tuberculin, purified protein derivative | tuberculin, purified protein derivative | tuberculin,purified protein derivative | tuberculin, purified protein derivative of | tuberculin, purified protein derivative (ppd) | tuberculinum | tubersol

Organizations (31)

Research & Development (29)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (9)

Approved Indications (1)


 

Tuberculosis

Experimental Indications - Clinical Trial Phases 1-4 (9)


 

Aged (Phase 4)

Asthma (Phase 2)

Condylomata Acuminata (Phase 3)

Healthy Volunteers (Early Phase 1)

HIV Infections (Phase 3)

Latent Tuberculosis (Phase 4)

Leprosy (Phase 2)

Tuberculosis (Phase 4)

Warts (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 22
  • # of Trial Organizations: 29

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue